Implementing guidelines on the prevention of opportunistic infections in inflammatory bowel disease

Journal of Crohn's and Colitis - Tập 7 - Trang e449-e456 - 2013
A.J. Walsh1, M. Weltman2, D. Burger3, S. Vivekanandarajah4, S. Connor4, M. Howlett5, G. Radford-Smith5,6, W. Selby7, A.S. Veillard8, M.C. Grimm9, S.P.L. Travis3, I.C. Lawrance10
1Department of Gastroenterology, St. Vincent's Hospital, Sydney, Australia
2Department of Gastroenterology, Nepean Hospital, Sydney, Australia
3Translational Gastroenterology Unit, John Radcliffe Hospital, Oxford, UK
4Department of Gastroenterology, Liverpool Hospital, Sydney, Australia
5Department of Gastroenterology, Royal Brisbane and Women’s Hospital, Brisbane, Australia
6IBD Group, Queensland Institute of Medical Research, University of Queensland School of Medicine, Herston Campus, Brisbane, Australia
7Department of Gastroenterology, Royal Prince Alfred Hospital, Sydney, Australia
8National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Sydney, Australia
9Department of Gastroenterology, St George Hospital, St George Clinical School, University of New South Wales, Sydney, Australia
10Centre for Inflammatory Bowel Diseases, School of Medicine and Pharmacology, University of Western Australia, Fremantle Hospital, Fremantle, Australia

Tài liệu tham khảo

Ramadas, 2010, Natural history of Crohn's disease in a population-based cohort from Cardiff (1986–2003): a study of changes in medical treatment and surgical resection rates, Gut, 59, 1200, 10.1136/gut.2009.202101 Feagan, 2008, Effects of adalimumab therapy on incidence of hospitalization and surgery in Crohn's disease: results from the CHARM study, Gastroenterology, 135, 1493, 10.1053/j.gastro.2008.07.069 Toruner, 2008, Risk factors for opportunistic infections in patients with inflammatory bowel disease, Gastroenterology, 134, 929, 10.1053/j.gastro.2008.01.012 Lawrance, 2010, Serious infective complications associated with anti-TNF therapy in inflammatory bowel disease: an Australian and New Zealand experience, J Gastroenterol Hepatol, 25, 1732, 10.1111/j.1440-1746.2010.06407.x Andrisani, 2012, Response to 2009 vaccine for influenza A/H1N1 in patients with inflammatory bowel disease on anti TNFa therapy, J Crohns Colitis, P159 Dotan, 2012, Influenza A H1N1 vaccine is safe and effective in patients with inflammatory bowel disease with thiopurine and TNF-a blocker, J Crohns Colitis, P259 Chaparro, 2012, Comparative study to evaluate the effectiveness of two different vaccination protocols against hepatitis B virus (HBV) in inflammatory bowel disease (IBD) patients, J Crohns Colitis, P233 Fiorino, 2012, Effect of immunosuppression on immune response to pneumococcal vaccine in inflammatory bowel disease: a prospective study, J Crohns Colitis, P201 Rahier, 2009, European evidence-based consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease, J Crohns Colitis, 3, 47, 10.1016/j.crohns.2009.02.010 Grol, 2005 Peake, 2012, Vaccination against opportunistic infections in patients with inflammatory bowel disease on immunomodulator therapy, J Crohns Colitis, P371 Watkins, 1999, General practitioners' use of guidelines in the consultation and their attitudes to them, Br J Gen Pract, 49, 11 Tan, 2012, General practitioners' knowledge of and attitudes to inflammatory bowel disease, Int Med J, 42, 801, 10.1111/j.1445-5994.2011.02586.x Kay, 1970, Cervical dysplasia and cancer developing in women on immunosuppressive therapy for renal transplantation, Cancer, 26, 1048, 10.1002/1097-0142(197011)26:5<1048::AID-CNCR2820260512>3.0.CO;2-M
Thông tin
Thông tin xuất bản

Journal of Crohn's and Colitis

Tập 7

e449-e456

Thông tin tác giả